U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Details

Stereochemistry ABSOLUTE
Molecular Formula C65H92N14O18S2
Molecular Weight 1421.639
Optical Activity UNSPECIFIED
Defined Stereocenters 10 / 10
E/Z Centers 0
Charge 0

SHOW SMILES / InChI
Structure of EDOTREOTIDE

SMILES

C[C@@H](O)[C@@H](CO)NC(=O)[C@@H]1CSSC[C@H](NC(=O)[C@@H](CC2=CC=CC=C2)NC(=O)CN3CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC3)C(=O)N[C@@H](CC4=CC=C(O)C=C4)C(=O)N[C@H](CC5=CNC6=C5C=CC=C6)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H]([C@@H](C)O)C(=O)N1

InChI

InChIKey=RZHKDBRREKOZEW-AAXZNHDCSA-N
InChI=1S/C65H92N14O18S2/c1-39(81)51(36-80)72-64(96)53-38-99-98-37-52(73-60(92)48(28-41-10-4-3-5-11-41)68-54(84)32-76-20-22-77(33-55(85)86)24-26-79(35-57(89)90)27-25-78(23-21-76)34-56(87)88)63(95)70-49(29-42-15-17-44(83)18-16-42)61(93)71-50(30-43-31-67-46-13-7-6-12-45(43)46)62(94)69-47(14-8-9-19-66)59(91)75-58(40(2)82)65(97)74-53/h3-7,10-13,15-18,31,39-40,47-53,58,67,80-83H,8-9,14,19-30,32-38,66H2,1-2H3,(H,68,84)(H,69,94)(H,70,95)(H,71,93)(H,72,96)(H,73,92)(H,74,97)(H,75,91)(H,85,86)(H,87,88)(H,89,90)/t39-,40-,47+,48-,49+,50-,51-,52+,53+,58+/m1/s1

HIDE SMILES / InChI

Molecular Formula C65H92N14O18S2
Molecular Weight 1421.639
Charge 0
Count
Stereochemistry ABSOLUTE
Additional Stereochemistry No
Defined Stereocenters 10 / 10
E/Z Centers 1
Optical Activity UNSPECIFIED

Edotreotide (SMT487) is a DOTA-containing somatostatin analog. Edotreotide binds with high affinity to somatostatin receptors. Somatostatin receptors are predominantly overexpressed by neuroendocrine tumors. On 15 September 2016, the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP) adopted a positive opinion, recommending granting a marketing authorisation for the orphan medicine edotreotide (SomaKit-TOC) intended for use in Positron Emission Tomography (PET) imaging in adult patients with gastro-enteropancreatic neuroendocrine tumours (GEP-NETs). SomaKit TOC was designated as an orphan medicinal product on 19 March 2015. 68Ga-Edotreotide, distributed under the brand name TOCscan® (Sogacin® in Austria/ France), is the companion diagnostic in ITM´s theranostic approach for the treatment of neuroendocrine tumors (NETs). N.c.a. 177Lu-Edotreotide is known as an innovative Targeted Radionuclide Therapy agent with favorable safety profile and promising efficacy. N.c.a. 177Lu-Edotreotide received an Orphan Designation as treatment of gastro-entero-pancreatic neuroendocrine tumors (GEP-NET) based on academic clinical Phase II data suggesting a significant benefit (substantially improved progression-free survival, PFS).

Approval Year

PubMed

PubMed

TitleDatePubMed
Locoregional regulatory peptide receptor targeting with the diffusible somatostatin analogue 90Y-labeled DOTA0-D-Phe1-Tyr3-octreotide (DOTATOC): a pilot study in human gliomas.
1999 May
Substance Class Chemical
Created
by admin
on Fri Dec 15 16:26:38 UTC 2023
Edited
by admin
on Fri Dec 15 16:26:38 UTC 2023
Record UNII
U194AS08HZ
Record Status Validated (UNII)
Record Version
  • Download
Name Type Language
EDOTREOTIDE
INN   MI   USAN  
INN   USAN  
Official Name English
DOTATOC
Common Name English
L-CYSTEINAMIDE, N-((4,7,10-TRIS(CARBOXYMETNYL)-1,4,7,10-TETRAAZACYCLODEC-1-YL)ACETYL)-D-PHENYLALANYL-L-CYSTEINYL-L-TYROSYL-D-TRYPTOPHYL-L-LYSYL-L-THREONYL-N-((1R,2R)-2-HYDROXY-1-(HYDROXYMETHYL)PROPYL)-, CYCLIC(2->7)-DISULFIDE
Common Name English
EDOTREOTIDE [USAN]
Common Name English
N-((4,7,10-TRIS(CARBOXYMETHYL)-1,4,7,10-TETRAAZACYCOLDODEC-1-YL)ACETYL-D-PHENYLALANYL-L-CYSTEINYL-L-TYROSYL-D-TRYPROPHYL-L-LYSYL-L-THREONYL-N-((1R,2R)-2-HYDROXY-1-(HYDROXYMETHYL)PROPYL)-L-CYSTEINAMIDE CYCLIC (2->7)-DISULFIDE
Common Name English
SMT487
Code English
SMT-487
Code English
edotreotide [INN]
Common Name English
EDOTREOTIDE [MI]
Common Name English
Classification Tree Code System Code
NCI_THESAURUS C62799
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
FDA ORPHAN DRUG 160902
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
Code System Code Type Description
CAS
204318-14-9
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
PRIMARY
ChEMBL
CHEMBL408350
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
PRIMARY
EVMPD
SUB179386
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
PRIMARY
SMS_ID
100000164814
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
PRIMARY
INN
8032
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
PRIMARY
PUBCHEM
158782
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
PRIMARY
MERCK INDEX
m4831
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
PRIMARY Merck Index
MESH
C106246
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
PRIMARY
FDA UNII
U194AS08HZ
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
PRIMARY
EPA CompTox
DTXSID701021591
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
PRIMARY
USAN
OO-07
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
PRIMARY
NCI_THESAURUS
C2616
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
PRIMARY
WIKIPEDIA
EDOTREOTIDE
Created by admin on Fri Dec 15 16:26:38 UTC 2023 , Edited by admin on Fri Dec 15 16:26:38 UTC 2023
PRIMARY
Related Record Type Details
SALT/SOLVATE -> PARENT
SALT/SOLVATE -> PARENT
LABELED -> NON-LABELED
PARENT -> DERIVATIVE
LABELED -> NON-LABELED
TARGET->LIGAND
LABELED -> NON-LABELED
SALT/SOLVATE -> PARENT
LABELED -> NON-LABELED
SALT/SOLVATE -> PARENT
Related Record Type Details
ACTIVE MOIETY